share_log
Reuters ·  Dec 11, 2024 21:15
Eli Lilly: As Combination Therapy, Imlunestrant Plus Verzenio Significantly Reduced Risk of Progression or Death by 43%, Vs Imlunestrant Alone
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment